Sodium Channel Blockers [Pharmacological Action]
Tree Number(s): D026941
MeSH Unique ID: D026941
- pilsicainide (Supplementary Concept)
- fosphenytoin (Supplementary Concept)
- SC 1001 (Supplementary Concept)
- WIN 17317-3 (Supplementary Concept)
- CNS 1237 (Supplementary Concept)
- ethyl 4-ethoxybenzoate (Supplementary Concept)
- dimethylaminoethyl p-butylaminobenzoate (Supplementary Concept)
- 1,3-bis(4-sec-butylphenyl)tetrahydropyrimidin-2-ylideneamine (Supplementary Concept)
- 1,3-bis(4-sec-butylphenyl)-4,5-dihydroimidazol-2-ylamine (Supplementary Concept)
- 2,4-diamino-5-(2,3-dichlorophenyl)-6-fluoromethylpyrimidine (Supplementary Concept)
- lysyl-isoleucyl-phenylalanyl-methionyl-lysine (Supplementary Concept)
- AM 36 (Supplementary Concept)
- BIIB 513 (Supplementary Concept)
- N,N-(diphenyl)-4-ureido-5,7-dichloro-2-carboxyquinoline (Supplementary Concept)
- N-(2,6-dimethylphenyl)-2-pyrrolidinecarboxamide (Supplementary Concept)
- N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-(4-(4-(2,3-dihydroxypropoxy)phenyl)butyl)guanidine (Supplementary Concept)
- PF-06456384 (Supplementary Concept)
- N-propyl-2,2-diphenyl-2-hydroxyacetamide (Supplementary Concept)
- Amiodarone (MeSH Term)
- Carbamazepine (MeSH Term)
- Tetrodotoxin (MeSH Term)
- Ranolazine (MeSH Term)
- Lamotrigine (MeSH Term)
- ethylisopropylamiloride (Supplementary Concept)
- PcTX1 protein, Psalmopoeus cambridgei (Supplementary Concept)
- ethotoin (Supplementary Concept)
- rufinamide (Supplementary Concept)
- eslicarbazepine acetate (Supplementary Concept)
- DS-1971a (Supplementary Concept)
- Amiloride (MeSH Term)
- Triamterene (MeSH Term)
- Moricizine (MeSH Term)
- Lidocaine (MeSH Term)
- Procainamide (MeSH Term)
- Propafenone (MeSH Term)
- Flecainide (MeSH Term)
- Ajmaline (MeSH Term)
- Aprindine (MeSH Term)
- Mexiletine (MeSH Term)
- Quinidine (MeSH Term)
- Disopyramide (MeSH Term)
- Phenytoin (MeSH Term)
- Tocainide (MeSH Term)
- Encainide (MeSH Term)
- Oxcarbazepine (MeSH Term)
- Lacosamide (MeSH Term)